Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice

Dis Model Mech. 2023 Oct 1;16(10):dmm050190. doi: 10.1242/dmm.050190. Epub 2023 Oct 13.

Abstract

Sezary syndrome (SS) is a rare, aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) that lacks adequate therapeutic options and representative small-animal models. Here, we demonstrate that IL-15 is a critical CTCL growth factor. Importantly, an immunodeficient knock-in mouse model genetically engineered to express human IL-15 uniquely supported the growth of SS patient samples relative to conventional immunodeficient mouse strains. SS patient-derived xenograft (PDX) models recapacitated key pathological features of the human disease, including skin infiltration and spread of leukemic cells to the periphery, and maintained the dependence on human IL-15 upon serial in vivo passaging. Detailed molecular characterization of the engrafted cells by single-cell transcriptomic analysis revealed congruent neoplastic gene expression signatures but distinct clonal engraftment patterns. Overall, we document an important dependence of Sezary cell survival and proliferation on IL-15 signaling and the utility of immunodeficient humanized IL-15 mice as hosts for SS - and potentially other T and NK cell-derived hematologic malignancies - PDX model generation. Furthermore, these studies advocate the thorough molecular understanding of the resultant PDX models to maximize their translational impact.

Keywords: CTCL; Humanized mice; IL-15; PDX; Sezary syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Interleukin-15
  • Lymphocytes / metabolism
  • Lymphoma, T-Cell, Cutaneous* / pathology
  • Mice
  • Sezary Syndrome* / metabolism
  • Sezary Syndrome* / pathology
  • Skin Neoplasms* / metabolism
  • Tumor Microenvironment

Substances

  • Interleukin-15